Lipstatin, an inhibitor of pancreatic lipase, produced by streptomyces toxytricini i. producing organism, fermentation, isolation and biological activity

327Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

Abstract

Lipstatin, a new and very potent inhibitor of pancreatic lipase (the key enzyme of in-testinal fat digestion) was isolated from Streptomyces toxytricini. Lipstatin contains a structure that probably accounts for the irreversible lipase inhibition. The IC50 of lipstatin for pancreatic lipase is 0.14. In mice triolein absorption was dose-dependently inhibited by lipstatin, whereas oleic acid was absorbed normally. Other pancreatic enzymes, such as phospholipase A2 and trypsin, were not inhibited even at an inhibitor concentration of 200 μm. © 1987, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Weibel, E. K., Hadvary, P., Hochuli, E., Kupfer, E., & Lengsfeld, H. (1987). Lipstatin, an inhibitor of pancreatic lipase, produced by streptomyces toxytricini i. producing organism, fermentation, isolation and biological activity. The Journal of Antibiotics, 40(8), 1081–1085. https://doi.org/10.7164/antibiotics.40.1081

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free